Facebook
Twitter
Telegram
Report an ErrorEledon Pharmaceuticals Financial Ratios 2011-2024 | ELDN
Annual Financial Ratios Eledon Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-1.3 | -0.4 | -1.5 | -0.4 | - | - | - | - | - | - | - | - | - |
P/S |
- | - | - | 81.0 | - | - | - | - | - | - | - | - | - |
EPS |
-1.6 | -6.2 | -2.3 | -15.7 | -24.4 | -1.6 | -2.3 | -2.5 | -2.0 | -3.6 | -38.0 | -31.1 | - |
EV (Enterprise Value) |
51.8 M | -14.4 M | -26 M | -97.9 M | -7.32 M | -10.4 M | -15.8 M | -20.3 M | -17.8 M | -101 M | 55.8 M | 40.2 M | - |
EBITDA per Share |
-1.75 | -6.19 | -2.49 | -30.5 | - | - | - | - | - | - | - | - | - |
EV/EBITDA |
0.9 | 5.2 | - | - | - | - | - | - | - | - | - | ||
PEG |
- | -0.0 | - | - | - | - | - | - | - | - | - | ||
P/B |
0.6 | 0.4 | 0.3 | 0.1 | - | - | - | - | - | - | - | - | - |
P/CF |
-1.3 | -1.2 | -1.8 | -0.6 | - | - | - | - | - | - | - | - | - |
ROE % |
-48.34 | -104.49 | -21.04 | -12.97 | - | - | - | - | - | - | - | - | - |
ROA % |
-45.28 | -94.80 | -20.23 | -12.54 | - | - | - | - | - | - | - | - | - |
ROCE % |
-51.55 | -105.04 | -22.48 | -10.26 | - | - | - | - | - | - | - | - | - |
Current Ratio |
15.8 | 10.8 | 26.0 | 46.6 | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Eledon Pharmaceuticals
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.34 | - | -0.35 | -0.4 | -0.75 | - | -0.73 | -0.65 | -0.69 | - | -0.66 | -0.5 | -0.57 | - | -5.51 | -2.74 | -8.52 | - | -4.01 | -0.35 | -0.52 | - | -0.37 | -0.34 | -0.36 | - | -0.43 | -1.32 | -0.59 | -0.17 | -4.35 | -2.25 | -0.51 | -0.49 | -0.53 | -0.4 | -0.59 | -0.28 | -2.71 | -11.68 | -9.79 | -11.23 | -6.82 | -12.95 | -7.2 | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | - | - | - | - | -0.74 | -0.65 | -0.69 | - | -0.71 | -0.54 | -0.61 | - | -5.51 | -2.74 | -3.52 | - | -4.04 | -0.35 | -0.52 | - | -0.37 | -0.34 | -0.36 | - | -0.42 | -1.6 | -3.34 | -9.54 | -19.7 | -11.7 | -0.51 | -0.49 | -0.53 | -0.4 | -0.59 | -0.28 | -2.72 | -11.7 | -9.87 | -11.2 | -6.81 | - | - | - | - | - | - | - | - | - | - |
ROE % |
-46.01 | -35.32 | -42.74 | -38.83 | -35.44 | -19.92 | -25.67 | -24.00 | -21.95 | -14.51 | -17.73 | -15.21 | -12.43 | -8.87 | -39.44 | -66.78 | -108.66 | -125.38 | -149.50 | -143.06 | -121.82 | -65.49 | -80.76 | -71.90 | -84.15 | -56.58 | 81.72 | 172.31 | 243.64 | 208.16 | -326.15 | -420.67 | -472.27 | -451.21 | -61.20 | -48.17 | -39.31 | -22.51 | -6.51 | 5.75 | 11.40 | 16.09 | 6.09 | - | - | - | - | - | - | - | - | - | - |
ROA % |
-43.25 | -32.83 | -39.83 | -36.06 | -33.06 | -19.09 | -24.63 | -23.17 | -21.20 | -13.98 | -17.10 | -14.67 | -11.98 | -8.57 | -35.04 | -58.39 | -94.52 | -108.56 | -129.10 | -123.16 | -104.45 | -55.74 | -69.96 | -63.64 | -76.80 | -52.68 | -365.14 | -521.07 | -572.96 | -604.78 | -308.53 | -155.82 | -85.21 | -66.33 | -55.88 | -44.38 | -36.63 | -21.62 | -32.97 | -37.46 | -32.03 | -27.53 | -10.42 | - | - | - | - | - | - | - | - | - | - |
ROCE % |
- | - | -7.51 | -15.02 | -21.24 | -20.03 | -26.19 | -24.83 | -23.08 | -15.52 | -18.74 | -15.81 | -12.71 | -6.36 | -37.21 | -64.83 | -106.67 | -125.56 | -149.70 | -143.00 | -121.80 | -65.44 | -80.61 | -71.63 | -83.47 | -56.11 | 87.51 | 165.30 | 235.75 | 200.11 | -329.29 | -411.18 | -462.32 | -441.13 | -61.39 | -48.33 | -39.49 | -22.67 | -6.58 | 5.72 | 11.40 | 16.13 | 6.09 | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
13.5 | 15.8 | 20.3 | 15.6 | 10.9 | 10.8 | 17.6 | 29.0 | 31.9 | 26.0 | 27.6 | 31.9 | 24.5 | 29.9 | 29.9 | 29.9 | 29.9 | 7.5 | 7.5 | 7.5 | 7.5 | 6.7 | 6.7 | 6.7 | 6.7 | 14.5 | 14.5 | 14.5 | 14.5 | 0.3 | 0.3 | 0.3 | 10.2 | 10.9 | 10.9 | 10.9 | 10.9 | 25.4 | 25.4 | 25.4 | 25.4 | 14.6 | 14.6 | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency